Raab & Moskowitz Asset Management LLC grew its stake in Pfizer Inc. (NYSE:PFE – Free Report) by 1.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 133,747 shares of the biopharmaceutical company’s stock after purchasing an additional 1,884 shares during the […]
Headlands Technologies LLC purchased a new stake in Pfizer Inc. (NYSE:PFE – Free Report) during the fourth quarter, according to its most recent disclosure with the SEC. The firm purchased 41,111 shares of the biopharmaceutical company’s stock, valued at approximately $1,184,000. Other hedge funds and other institutional investors have also recently bought and sold shares […]
Intellectus Partners LLC increased its stake in Pfizer Inc. (NYSE:PFE – Free Report) by 11.1% during the fourth quarter, according to its most recent filing with the SEC. The fund owned 83,435 shares of the biopharmaceutical company’s stock after buying an additional 8,352 shares during the quarter. Intellectus Partners LLC’s holdings in Pfizer were worth […]
Private Wealth Partners LLC reduced its position in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 9.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 425,358 shares of the biopharmaceutical company’s stock after selling 43,646 shares […]
Leisure Capital Management reduced its holdings in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 4.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 11,988 shares of the biopharmaceutical company’s stock after selling 556 shares during the quarter. Leisure Capital Management’s […]